Vuruşkan, Berna AytaçÖzşen, MineCoşkun, BurhanYalçınkaya, Ülviye2024-07-172024-07-172019-01-011677-5538https://doi.org/10.1590/S1677-5538.IBJU.2018.0048https://www.scielo.br/j/ibju/a/wpZscyqQX6BYPss63SWjpCJ/https://europepmc.org/backend/ptpmcrender.fcgihttps://hdl.handle.net/11452/43302Purpose: In this study we aimed to review urological soft tissue sarcomas of genitourinary tract that were diagnosed in our institution and their prognostic factors for survival.Materials and Methods: The clinical and pathological records of 31 patients who had diagnosis of soft tissue sarcomas primarily originating from the genitourinary tract between 2005-2011 were reviewed.Results: The most common site was kidney (17 cases, 54.8%), and most common diagnosis was leiomyosarcoma (11 cases, 35.4%). A total of 24 patients (77.4%) had surgical excision. The surgical margins were positive in 7 patients who presented with local recurrence after primary resection. Twelve patients developed metastatic disease. During follow-up (range 9-70 month), 26 of the 31 patients (88.9%) were alive. Significant survival differences were found according to histological type (p: 0.001), with lower survival rates for malignant fibrous histiocytoma. The tumor size, the presence of metastasis at the time of diagnosis and tumor localization were not statistically significant for overall survival.Conclusions: In our series, prostate sarcomas, paratesticular rhabdomyosarcoma and malignant fibrous histiocytoma had poor prognosis, especially in patients presenting with metastatic disease.eninfo:eu-repo/semantics/openAccessNerve sheath tumorLeiomyosarcomaProstateBladderGenitourinary tract anomalies [supplementary concept]SarcomaSurvivalScience & technologyLife sciences & biomedicineUrology & nephrologyArticle000459340200011687345110.1590/S1677-5538.IBJU.2018.00481677-6119